MLAB Form 8-K furnishes press release for quarter ended June 30, 2025

Rhea-AI Filing Summary

On August 5, 2025, Mesa Laboratories, Inc. (Ticker: MLAB) filed a Form 8-K reporting that it issued a press release relating to its results for the three months ended June 30, 2025. The press release is furnished as Exhibit 99.1 to the Form 8-K.

The Form 8-K states that the information furnished in Item 2.02 and Exhibit 99.1 shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act and shall not be incorporated by reference into registration statements under the Securities Act. The filing also lists Exhibit 104 (Cover Page Interactive Data File). The report is signed by Gary M. Owens, President and Chief Executive Officer, dated August 5, 2025, and includes the registrant address and Nasdaq listing (symbol MLAB).

Insights

Financial Analyst

TL;DR: Routine Form 8-K furnishing a press release on Q2 results; the filing itself does not state financial metrics.

The filing notifies investors that Mesa Laboratories furnished a press release dated August 5, 2025 relating to results for the three months ended June 30, 2025 and attaches that release as Exhibit 99.1. The document explicitly states the furnished information is "not deemed to be filed" for Section 18 purposes, limiting statutory liabilities for the filing itself. For investors seeking quantitative detail, the Exhibit 99.1 press release referenced in the filing is the primary source; the Form 8-K text contains no financial figures or guidance.

Corporate Governance Expert

TL;DR: Governance filing signed by CEO; exhibits listed (99.1 and 104); communication-related checkbox items are presented but not marked as checked.

The Form 8-K is executed by Gary M. Owens, President and CEO, and lists Exhibit 99.1 (press release dated August 5, 2025) and Exhibit 104 (Cover Page Interactive Data File). The filing includes the standard checkboxes for Rule 425 and solicitation/pre-commencement communications (displayed but not indicated as checked in the filing text). The statement that the press release is furnished and not "filed" under Section 18 is a disclosure control point affecting how the release may be treated in subsequent filings or incorporation by reference.

false 0000724004 0000724004 2025-08-05 2025-08-05

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549   

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): AUGUST 5, 2025

MESA LABORATORIES, INC.
(Exact name of registrant as specified in its charter)

Colorado
(State or other jurisdiction of
incorporation) 0-11740 (Commission File Number) 84-0872291
(I.R.S. Employer
Identification No.)

12100 WEST SIXTH AVENUE, LAKEWOOD, Colorado
(Address of principal executive offices) 80228
(Zip Code)

Registrant’s telephone number, including area code: 303-987-8000

Not Applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered under Section 12(b) of the Act:

Title of each class		Trading Symbol		Name of each exchange on which registered
Common Stock, no par value		MLAB		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION

On August 5, 2025, Mesa Laboratories, Inc. issued a press release relating to its results for the three months ended June 30, 2025. A copy of the press release is furnished herewith as Exhibit 99.1.

The information furnished in Item 2.02 of this Current Report on Form 8-K and Exhibit 99.1 attached hereto shall not be deemed to be filed for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liabilities of that section, and shall not be deemed to be incorporated by reference into any registration statement or other document filed pursuant to the Securities Act of 1933, as amended.

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS

(d) Exhibits:

99.1 Press release dated August 5, 2025.

104 Cover Page Interactive Data File (embedded withing the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

DATE: August 5, 2025		Mesa Laboratories, Inc.
		(Registrant)
	BY:	/s/ Gary M. Owens
		Gary M. Owens
		President and Chief Executive Officer

FAQ

What did Mesa Laboratories (MLAB) disclose in the Form 8-K filed Aug 5, 2025?

The company furnished a press release dated August 5, 2025 relating to results for the three months ended June 30, 2025, filed as Exhibit 99.1 to Form 8-K.

Is the press release included in the filing considered "filed" under the Exchange Act?

No. The Form 8-K states the information furnished in Item 2.02 and Exhibit 99.1 "shall not be deemed to be filed" for purposes of Section 18 of the Securities Exchange Act.

Which exhibits are listed in the August 5, 2025 Form 8-K by Mesa Laboratories?

The filing lists Exhibit 99.1 (press release dated August 5, 2025) and Exhibit 104 (Cover Page Interactive Data File).

Who signed the Form 8-K for Mesa Laboratories and when?

The Form 8-K is signed by Gary M. Owens, President and Chief Executive Officer, dated August 5, 2025.

Does the Form 8-K text include financial results or metrics for Q2 2025?

The Form 8-K text only states a press release was furnished regarding results for the three months ended June 30, 2025; the filing text does not include any financial figures. Financial detail would be in Exhibit 99.1.